Back to Search
Start Over
Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide.
- Source :
-
Haematologica [Haematologica] 2018 Apr; Vol. 103 (4), pp. e143-e146. Date of Electronic Publication: 2017 Dec 21. - Publication Year :
- 2018
- Subjects :
- Disease Progression
Female
Humans
Lenalidomide therapeutic use
Male
Middle Aged
Myelodysplastic Syndromes classification
Myelodysplastic Syndromes diagnosis
Prognosis
Chromosome Deletion
Chromosomes, Human, Pair 5
Mutation
Myelodysplastic Syndromes genetics
Tumor Suppressor Protein p53 genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 103
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Editorial & Opinion
- Accession number :
- 29269520
- Full Text :
- https://doi.org/10.3324/haematol.2017.181404